By Matt Gretczko – There has been a lot of dialogue lately regarding CMS’s potential expansion of a star rating system to providers. Not surprisingly, it is being rather heavily opposed.
Read More
By John Halamka, MD – CMS announced their intent to update the Medicare and Medicaid EHR Incentive Programs for 2015 and beyond. ONC released the Interoperability Roadmap and the Standards Advisory. A busy week. What does it all mean?
By Beth Kelly – Now that the 2015 Consumer Electronics Show is over, the tech world is buzzing over the latest and greatest products that were debuted and displayed there by companies big and small. One trend that has only grown in recent years at CES is the presence of health technology at the show and it’s slowly becoming a part of mainstream consumers’ everyday life.
By Tricia Lee Wilkins & Meghan Gabriel – Over the past couple of years, EPCS – the electronic prescribing of controlled substances – has increased dramatically. This has potential benefits for both patients and health care system costs.
By John Halamka, MD – The January HIT Standards Committee focused on two important topics, the future of the Standards and Interoperability (S&I) Framework and the standards needed for provenance i.e. who generated the data and I can I trust it?
By Daniel J. Marino – Organizations that begin to incorporate strategies around the “value proposition” will be in the best position to meet industry demands for value-based reimbursement. This will require a dedicated strategic “call to action” across organizations and their provider community.
By Robert Rowley, MD. Health information exchange (the verb) has been the goal of health IT, now that we have moved into the “post-EHR adoption” era of healthcare. Published and private surveys have shown that about 80% of physician practices have implemented an Electronic Health Record (EHR)…
One of the ways that HITECH Answers is different from other media sites is the sense of community. The thought leaders in our community are…
By Owen Faris & Jeffrey Shuren – At the Center for Devices and Radiological Health (CDRH), clinical trials are the foundation for our decisions to approve the most important medical devices—products that have the potential to save or sustain life, but that also present the greatest risk to patients.